Posts Tagged: researcher

News

USC pays UCSD $50 million to settle recruitment fight

Students outside the library at the University of California, San Diego. (Photo: Stanislavsky, via Shutterstock)

The University of Southern California in Los Angeles is coughing up $50 million and publicly apologizing for its tactics in recruiting a star Alzheimer’s researcher from UC San Diego, it was reported Thursday. The Los Angeles Times story about the unprecedented settlement described the case as an “ugly academic war.” It had the potential of bringing $340 million in research grants to USC.  

Recent News

A European view of California’s stem cell agency

A pipette and recepticles used in stem cell research. (Photo: CI Photos)

Some folks in Europe are worried about stem cell research, particularly about organizations like California’s $3 billion stem cell agency. The alarm was sounded just yesterday in Horizon, which calls itself  “The EU Research and Innovation Magazine.”

News

Stem cell researcher enters political fray

UC Irvine neurobiologist Hans Keirstead, a Democrat running for Congress against Rep. Dana Rohrabacher in Orange County. (Photo: UC Irvine)

A relatively obscure stem cell scientist last week one-upped — sort of — one of the more powerful lawmakers in the United States Senate. It was not a direct, head-to-head contest — just sort of a rough comparison involving Democratic politics in California.

Analysis

CA120: In political polling, art and science join hands

The attitudes of voters. Illustration by Niroworld, via Shutterstock.

Friday night, my wife Jodi got home after a long week. Trying to decide what we should do, she flipped through some channels, looking at the networks, a couple sports channels, a few news channels, HBO and Showtime, and then finally announced “I don’t think there’s anything good on TV, let’s go see a movie.”

News

State bets $30 million on new cancer treatment

A scientist works in a biological laboratory. (Photo: Anya Ivanova, via Shutterstock)

A new stem cell company that targets cancer by unleashing an “eat me” trigger has emerged from a $30 million investment by the state of California. Creation of the Palo Alto firm, which is called Forty Seven, Inc., was announced Feb. 24 by its backers and its key researcher, Irv Weissman, director of Stanford University’s stem cell program.

Support for Capitol Weekly is Provided by: